InvestorsHub Logo
Followers 25
Posts 3138
Boards Moderated 0
Alias Born 03/20/2019

Re: None

Monday, 09/28/2020 8:43:36 AM

Monday, September 28, 2020 8:43:36 AM

Post# of 403389
https://covid-19tracker.milkeninstitute.org/#treatment_antibodies



INNOVATION PHARMACEUTICALS
BRILACIDIN, A DEFENSIN MIMETIC
CLINICAL
Phase II trial anticipated to start Q4 2020
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News